For psoriasis, molecular signature in healthy-appearing skin may be best predictor of response to anti-TNF treatment

Researchers say finding predictive signs in a patient’s genetic profile is a step toward applying precision medicine to complex inflammatory skin diseases.

11:17 AM

Author | Noah Fromson

hands scratching wrist inflammation red
Getty Images

It's common for people with psoriasis to develop dry, inflamed skin lesions. However, the normal-appearing skin may hold the key to predict whether certain medications will work for patients.

A Michigan Medicine study, published in the Journal of Allergy and Clinical Immunology, analyzed patients with chronic plaque psoriasis being treated with etanercept, a drug used to reduce tumor necrosis factor. TNF is a critical inflammatory mediator released by immune cells in psoriatic skin lesions and is found to be elevated in the blood of patients with psoriasis.

Investigators found that specific gene expression changes in healthy-appearing skin were a better predictor of clinical response than changes in inflamed psoriasis skin. The findings could have major implications for improving treatment efficacy and identifying patients who are likely to respond, thereby limiting unnecessary drug exposures, said Lam Tsoi, Ph.D., lead author of the paper and an assistant professor of dermatology at Michigan Medicine.

SEE ALSO: For psoriasis, targeting skin protein may help control inflammation

"Up to one-fifth of psoriasis patients have been treated with the anti-TNF agent etanercept, yet only around half show a robust clinical response, and until now we have lacked the ability to predict who is going to respond and who will not," Tsoi said. "Efficient drug response assessment allows us to identify those who will do well on treatment and avoid wasting time and resources on medications that don't work."

Like Podcasts? Add the Michigan Medicine News Break on iTunes, Google Podcasts or anywhere you listen to podcasts.

The team took several skin biopsies of both healthy-appearing and inflamed skin from approximately 40 patients being treated with etanercept over a period of 12 weeks. They used the Psoriasis Area and Severity Index, a commonly used assessment tool for psoriasis, to measure disease activity before and during treatment. Surprisingly, while the molecular profile in healthy-appearing skin was predictive of treatment effectiveness, inflamed skin provided very little predictive information.

Healthy-appearing skin from patients with psoriasis has been known to have subtle sub-clinical changes.  While the reason for those changes is unclear, Tsoi and the research team believe it may reflect the overall inflammation and effect of genetic factors carried by psoriasis patients.

SEE ALSO: Genetic Prediction Model Helps Identify Arthritis Risk in Psoriasis Patients

"The complex nature of the inflammation in inflamed psoriatic skin might make it more 'noisy' and therefore not as helpful in the drug response assessment," Tsoi said. "Future studies will need to assess whether this process can be replicated to predict response for other drugs in psoriasis."

Etanercept is one of several anti-TNF therapies approved to treat psoriasis and one of many biologic drugs used in its treatment.

"Finding these predictive signs in a patient's genetic profile is one of the first steps to applying precision medicine to complex inflammatory skin diseases," said Johann Gudjonsson, M.D., Ph.D., senior author of the paper and Arthur C. Curtis Professor of Skin Molecular Immunology at Michigan Medicine. 

A major emphasis of the work in Tsoi's and Gudjonsson's laboratories is to gain a deeper understanding of the pathologic mechanisms in psoriasis and assess how such information may be used to predict clinical course, treatment responses and help move the research field towards a cure for psoriasis.

Paper cited: "Cytokine responses in nonlesional psoriatic skin as clinical predictor to anti-TNF agents," Journal of Allergy and Clinical Immunology. DOI: 10.1016/j.jaci.2021.07.024

MORE FROM THE LAB: Subscribe to our weekly newslette

More Articles About: Lab Report Psoriasis Medication Interactions Basic Science and Laboratory Research Skin Conditions
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]


Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Featured News & Stories teal persons body looks like a puzzle red heart top right of shoulder and chest getting placed into missing piece spot
Health Lab
Normothermic perfusion system extends life of organs waiting for transplant
A team of researchers have spent the past eight years looking at better ways to transport organs for donation, specifically hearts, to improve the number of organs that can be used for transplants. They found that using a modified normothermic perfusion system heart preservation was feasible for up to 24 hours.
yellow grey heart black background
Health Lab
Researchers create human aortic aneurysm model to advance disease understanding, treatment testing
Using human cells in an animal body, a team of researchers has developed a functional model of thoracic aortic aneurysm, creating opportunities for more effective understanding of disease development and treatments for the potentially fatal condition.
Health Lab
Too much iron can cause big problems for the immune system
A study builds on previous work that found depriving T cells of iron prevented cells from proliferating. The current study, published in PNAS, found that excess iron is just as problematic.
uti written on empty roll of toliet paper on a toliet paper holder with hot pink background
Health Lab
How E. coli get the power to cause urinary tract infections
Research published in PNAS examines how the bacteria Escherichia coli, or E. coli—responsible for most UTIs—is able to use host nutrients to reproduce at an extraordinarily rapid pace during infection despite the near sterile environment of fresh urine.
Xray of a stem cell in a mouse brain.
Health Lab
Stem cells improve memory, reduce inflammation in Alzheimer’s mouse brains
Researchers improved memory and reduced neuroinflammation in a mouse model of Alzheimer’s Disease, suggesting another avenue for potential treatment.
Illustration of a microscope
Health Lab
Helpful enzymes vanish in many patients with antiphospholipid syndrome
Researchers recently revealed a new mechanism behind antiphospholipid syndrome that the investigators hope will eventually allow treatments to be targeted closer to the source of the problem.